Русский
English
About
About Journal
Goals and objectives of the journal
Editorial council
Contacts
Journal Archive
Subscription
To authors
Copyright agreement
Procedure for reviewing
Requirements for publications
Send article
Privacy Declaration
Conflicts of Interest Declaration
Criteria for authorship
Ethical Standards
Search Articles by Keyword
Found:
7
articles
Article
Edition
A.S. Ametov
ADVANTAGES OF FIXED COMBINATION OF SAXAGLIPTIN AND METFORMIN WITH MODIFIED RELEASE (KOMBOGLYCE PROLONG) IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS
№5 / 2015
А.А. Yuryatin
THE SAVOR TRIAL: THE BEGINNING OF THE NEW ERA OF SAFE PHARMACOTHERAPY FOR TYPE-2 DIABETES MELLITUS
№5 / 2014
A.S. Ametov
ADVANTAGES OF THE NEW FIXED COMBINATION OF SAXAGLIPTIN AND TIME-RELEASE METFORMIN IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS
№16 / 2013
A.S. Ametov, MD, Professor; A.V. Braschenkova
Rational Pharmacotherapy Of Type 2 Diabetes Mellitus: Use Of Dpp-4 Inhibitor Saxagliptin And Metformin In Clinical Practice
№16 / 2012
M.B. Antsiferov (1), N.A. Petunina (2)
Type 2 Diabetes Mellitus And Concomitant Diseases: Advantages Of Use Of Dipeptidyl Peptidase-4 Inhibitor Saxagliptin (onglyza ®)
№3 / 2012
N.A. Petunina, A.V. Brashcenkova
Saxagliptin (onglyza ®) In Conception Of Effective Management Of Type 2 Diabetes Mellitus
№16 / 2011
A.M. Mkrtumyan
Saxagliptin Opens New Opportunities For Effective And Safe Glycemic Control In Patients With Type 2 Diabetes Mellitus
№16 / 2010
About
About Journal
Goals and objectives of the journal
Editorial council
Contacts
Journal Archive
Subscription
To authors
Copyright agreement
Procedure for reviewing
Requirements for publications
Send article
Privacy Declaration
Conflicts of Interest Declaration
Criteria for authorship
Ethical Standards
{"loading":"Loading...","close":"Close","yes":"Yes","no":"No","proceed":"Proceed","conf_del":"Do you really want to delete","cancel":"Cancel"}